Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1731-1738

  Wang, Lan ^a,b   Gao, Rui ^a   Yu, Long ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; P73; Polymorphism

Indexed keywords

PROTEIN P73; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEAD AND NECK CANCER; HETEROZYGOTE; HUMAN; LUNG CANCER; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SMOKING; STOMACH CANCER; UTERINE CERVIX CANCER; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84860335596     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0913-0     Document Type: Article

References (53)

1. Wang L, He G, Zhang P, Wang X, Jiang M, Yu L (2011) Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Mol Biol Rep 38:229-236
2. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819 (Pubitemid 27357971)
3. Benard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21:182-191 (Pubitemid 36292961)
4. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D (2000) p73-deficient mice have neurological, phero-monal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103 (Pubitemid 30143141)
5. Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371-386 (Pubitemid 39031071)
6. Marabese M, Vikhanskaya F, Broggini M (2007) p73: a chiaroscuro gene in cancer. Eur J Cancer 43:1361-1372 (Pubitemid 46874062)
7. Kovalev S, Marchenko N, Swendeman S, LaQuaglia M, Moll UM (1998) Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ 9:897-903 (Pubitemid 28514285)
8. Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, Liu W (1998) Activation of p73 silent allele in lung cancer. Cancer Res 58:2347-2349 (Pubitemid 28252692)
9. Zaika AI, Kovalev S, Marchenko ND, Moll UM (1999) Over-expression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 59:3257-3263 (Pubitemid 29316031)
10. Kang MJ, Park BJ, Byun DS, Park JI, Kim HJ, Park JH, Chi SG (2000) Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 6:1767-1771
11. Cai YC, Yang GY, Nie Y, Wang LD, Zhao X, Song YL, Seril DN, Liao J, Xing EP, Yang CS (2000) Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogen-esis 21:683-689 (Pubitemid 30214025)
12. Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI, Liu W (1999) Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 18:1629-1633 (Pubitemid 29108063)
13. Zwahlen D, Tschan MP, Grob TJ, Peters UR, Fink D, Haenggi W, Altermatt HJ, Cajot JF, Tobler A, Fey MF, Aebi S (2000) Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours. Int J Cancer 88:66-70
14. Sun XF (2002) p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 8:165-170
15. Guan M, Peng HX, Yu B, Lu Y (2003) p73 overexpression and angiogenesis in human colorectal carcinoma. Jpn J Clin Oncol 33:215-220 (Pubitemid 43115261)
16. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM (2002) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196:765-780
17. Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM (2004) Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epi-genetic p53 inhibitors in vivo. Cancer Res 64:2449-2460 (Pubitemid 38523899)
18. Peters MA, Janer M, Kolb S, Jarvik GP, Ostrander EA, Stanford JL (2001) Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. Prostate 48:292-296 (Pubitemid 32816555)
19. Li G, Wang LE, Chamberlain RM, Amos CI, Spitz MR, Wei Q (2004) p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res 64:6863-6866 (Pubitemid 39330992)
20. Niwa Y, Hamajima N, Atsuta Y, Yamamoto K, Tamakoshi A, Saito T, Hirose K, Nakanishi T, Nawa A, Kuzuya K, Tajima K (2004) Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett 205:55-60 (Pubitemid 38230139)
21. Zheng L, Pan X, Yang A, Zheng X, Wang X, Zhou Q, Li X (2008) Study of p73G4A polymorphism in HPV-associated cervical carcinoma in Uigur woman in Xinjiang. Chin J Mod Med 18:2302-2306
22. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, Shinoda M, Kodera Y, Yamamura Y, Hirai T, Kato T, Tajima K (2002) No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 181:81-85 (Pubitemid 34326437)
23. Pfeifer D, Arbman G, Sun XF (2005) Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcino-genesis 26:103-107 (Pubitemid 40207704)
24. Arfaoui AT, Kriaa LB, El Hadj OE, Ben Hmida MA, Khiari M, Khalfallah T, Gharbi L, Mzabi S, Bouraoui S (2010) Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients. Virchows Archiv
25. Ryan BM, McManus R, Daly JS, Carton E, Keeling PW, Reynolds JV, Kelleher D (2001) A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer 85:1499-1503 (Pubitemid 34001580)
26. Ge H, Wang YM, Cao YY, Chen ZF, Wen DG, Guo W, Wang N, Zhang XF, Li Y, Zhang JH (2007) The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis Esophagus 20:290-296 (Pubitemid 47054757)
27. Ge H, Wang YM, Cao YY, Zhang XF, Li Y, Guo W, Wang N, Zhang JH (2006) Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma. Ai Zheng 25:1351-1355
28. Zhang W, Wang X, Xie X, Guo F, Yang R, Liu Y, Xu S, Yang Y (2008) Association of the p73 gene G4C14-to-A4T14 polymor phism with increased gastric cancer risk in a northwestern Chinese population. Chin J Clin Oncol 5:157-160
29. De Feo E, Persiani R, La Greca A, Amore R, Arzani D, Rausei S, D'Ugo D, Magistrelli P, van Duijn CM, Ricciardi G, Boccia S (2009) A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat Res 675:60-65
30. Li G, Sturgis EM, Wang LE, Chamberlain RM, Amos CI, Spitz MR, El-Naggar AK, Hong WK, Wei Q (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squa-mous cell carcinoma of the head and neck. Carcinogenesis 25:1911-1916 (Pubitemid 39405910)
31. Chen X, Sturgis EM, Etzel CJ, Wei Q, Li G (2008) p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer 113:3307-3314
32. Galli P, Cadoni G, Volante M, De Feo E, Amore R, Giorgio A, Arzani D, Paludetti G, Ricciardi G, Boccia S (2009) A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer 9:137
33. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B, Roychoudhury S (2009) Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog 48:790-800
34. Hiraki A, Matsuo K, Hamajima N, Ito H, Hatooka S, Suyama M, Mitsudomi T, Tajima K (2003) Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac J Cancer Prev 4:107-112
35. Hu Z, Miao X, Ma H, Tan W, Wang X, Lu D, Wei Q, Lin D, Shen H (2005) Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer 114:455-460 (Pubitemid 40279969)
36. Choi JE, Kang HG, Chae MH, Kim EJ, Lee WK, Cha SI, Kim CH, Jung TH, Park JY (2006) No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem Genet 44:543-550
37. Han JL, Colditz GA, Hunter DJ (2006) Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk. Cancer Epidemiol Biomarkers Prev 15:592-593
38. Li C, Chen K, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q (2008) Polymorphisms of TP53 Arg72Pro, but not p73 G4C14[A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. J Invest Dermatol 128:1585-1588 (Pubitemid 351693182)
39. Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, Iwata H, Miura S, Xiang J, Tokudome S, Tajima K (2003) Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 10:307-311
40. Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N (2005) Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 219:183-190 (Pubitemid 40269482)
41. Hishida A, Matsuo K, Tajima K, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Naoe T, Hamajima N (2004) Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Leuk Lymphoma 45:957-964 (Pubitemid 38444672)
42. Kang S, Wang DJ, Li WS, Wang N, Zhou RM, Sun DL, Duan YN, Li SZ, Li XF, Li Y (2009) Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women. Int J Gynecol Cancer 19:572-577
43. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
44. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
45. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
46. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557-560 (Pubitemid 37088507)
47. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
48. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634 (Pubitemid 27387172)
49. Imyanitov EN (2009) Gene polymorphisms, apoptotic capacity and cancer risk. Hum Genet 125:239-246
50. Zhu Y, Wang J, He Q, Zhang JQ (2011) Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis. Mol Biol Rep 38:1603-1607
51. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG Jr (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25:47-54 (Pubitemid 30257035)
52. Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR (2006) Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev 15:158-161
53. Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G (2008) Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 29:2120-2125